Skip to main content

U.S. Drug Pricing Policy: Tools to Increase Access and Affordability

Bipartisan Policy Center
1225 Eye Street NW
Suite 1000
Washington, DC 20005
This event has passed.

Reflecting the American public’s concerns about access to necessary medications, Congress and the administration have proposed various policies to curb high drug prices. The Bipartisan Policy Center set out to explore the implications of using pharmaceutical reference pricing – both internal and external – in the United States. Both types of reference pricing are used commonly in other countries to mitigate the high price of drugs. Please join us as we release a report on our findings and host policymakers and experts to discuss potential policy solutions which address the high costs of drugs in the United States.


Keynote remarks by:

Sen. Rick Scott (R-FL)

Panel featuring:

Dr. Peter Bach
Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center

Mark Boutin
CEO, National Health Council

David Henka
President & CEO, ActiveRADAR

Natalie Hamm
Senior Policy Analyst, Bipartisan Policy Center

Wendell Primus
Senior Policy Advisor on Budget and Health issues to Speaker Nancy Pelosi

Dr. Sabine Vogler
Head of the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies

Moderated by:

Avik Roy
President, Foundation for Research on Equal Opportunity

More Upcoming Events

Red background with zig-zag pattern